Semble has raised £30 million in Series C funding to expand its healthcare management platform and strengthen its market position across the UK and France.
The funding round was led by Revaia, with participation from Partech, Mercia Ventures, and Octopus Ventures. The capital injection will enable the healthtech firm to deepen its presence among large healthcare groups while accelerating the development of artificial intelligence-powered care orchestration technologies.
Scaling across Europe
The investment marks a significant milestone for Semble as it seeks to establish itself as a key player in modernising healthcare delivery across Europe. The company plans to deploy the fresh capital towards building stronger relationships with major healthcare organisations and expanding its operational footprint beyond its current strongholds.
Christoph Lippuner, Semble’s leadership, articulated the company’s strategic vision during the announcement: “What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.”
AI-powered orchestration at the centre
The funding highlights growing investor confidence in Semble’s approach to addressing fragmentation in healthcare systems. By developing sophisticated AI capabilities that coordinate care across multiple touchpoints and providers, the company aims to help healthcare organisations deliver more seamless patient experiences.
The emphasis on care orchestration reflects a broader trend in European healthtech, where companies are increasingly using artificial intelligence and data integration to break down silos between different parts of the healthcare system. This approach promises to reduce inefficiencies, improve patient outcomes, and create better experiences for both patients and clinicians.
European healthtech momentum
Semble’s latest fundraising demonstrates the continued strength of investment into UK and European healthtech despite broader economic uncertainties. The backing of established venture firms including Partech, which has built a strong track record investing across European tech hubs, underscores the sector’s appeal to institutional investors seeking to support digital transformation in healthcare.
The UK remains a significant nucleus for healthtech innovation, with numerous startups addressing challenges ranging from clinical workflow optimisation to patient engagement. Semble’s expansion plans, particularly its focus on France alongside its UK operations, reflect a wider trend of successful British healthtech firms looking to replicate their models across continental Europe where healthcare systems face similar pressures around efficiency and patient-centricity.
As healthcare organisations across the continent grapple with mounting demand and resource constraints, software platforms that promise to optimise care delivery are attracting sustained investment attention, positioning Semble within a robust ecosystem of companies driving digital health innovation.